Polypill Trials for Stroke Prevention-Main Results, Critical Appraisal, and Implications for US Population.

Ibraheem, Mam; Goldstein, Larry B

Ibraheem, Mam; Goldstein, Larry B.

Affiliation

Ibraheem M; Department of Neurology, University of Kentucky, 740 South Limestone KY Clinic, J401, Lexington, KY, 40536, USA. Mam.Ibraheem@uky.edu.
Goldstein LB; The Department of Veterans Affairs Lexington VA Medical Center, Troy Bowling Campus, Lexington, KY, USA. Mam.Ibraheem@uky.edu.

Curr Neurol Neurosci Rep ; 20(5): 10, 2020 04 15.

Article in En | MEDLINE | ID: mdl-32296941

Subject(s)

Cardiovascular Agents; Cardiovascular Diseases; Stroke; Antihypertensive Agents; Cardiovascular Agents/therapeutic use; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/prevention & control; Drug Combinations; Humans; Medication Adherence; Stroke/drug therapy; Stroke/prevention & control

Key words

Clinical trial; Drug combinations; Polypill; Primary prevention; Secondary prevention; Stroke

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Agents / Cardiovascular Diseases / Stroke Type of study: Clinical_trials Limits: Humans Language: En Journal: Curr Neurol Neurosci Rep Journal subject: NEUROLOGIA Year: 2020 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google